Our Vision
We aim to become the recognised leader in the diagnosis, treatment and care management of individuals experiencing cognitive impairment.
Our Mission
We provide the best clinical quality and customer experience in mental health diagnostic and treatment services for the benefit of our patients, referring clinicians, employers and investors.
-
Dr. Emer MacSweeney
Consultant Neuroradiologist
-
Tom S. Dent
Executive Chairman
-
Dr. Steven Allder
Consultant Neurologist
-
Vicky Eyre
Director of Clinical Trials UK
-
Dr. Mostafa Hassan, MBBCh
Director of Clinical Trials USA
-
Penny Muir
Executive Assistant to Dr J Emer MacSweeney
-
Dr. Philip Paul Nichols
Consultant Neurologist
-
Dustin Reibe
Director of Operations
-
George Robinson
Global Patient Enrolment Advisor
-
Veronika Sudi
Finance Director
Our Values
-
Communication
We communicate effectively and share information proactively.
-
Excellence
We pursue continual improvement in who we are and what we do.
-
Relationships
We treat all individuals with respect, dignity and honesty.
-
Integrity
We will conduct our business in an honest and ethical way.
-
Results
We do not make excuses for less than optimal performance.
-
Measurement
We will measure our performance to ensure our resources are used effectively.
-
Service
We provide patients and clinicians with a value experience.
Committed To A World Of Healthy Brains and Minds
Perhaps the most impactful global health crisis of our lifetime is brain and mind health; from Alzheimer’s disease and other forms of cognitive impairment to mental health challenges affecting lives and societies around the world.
The inconsistency in diagnosing and treating patients with cognitive impairment in a clear and timely way compelled Neuro-Radiologist Dr. Emer MacSweeney, CEO, and healthcare business leader Tom Dent, Executive Chairman, to launch Re:Cognition Health. They believed a multi-disciplinary team providing the right clinical pathway to diagnose cognitive impairment was essential; along with the importance of providing hope, by making available the new and emerging international clinical drug trials in a supportive, compassionate and convenient environment.
Re:Cognition Health opened its first clinic in London in 2011 and quickly became an acknowledged leader in brain and mind health. Today, the company is comprised of transatlantic teams of passionate and caring experts, delivering hope, and brain and mind healthcare at the very highest level.
Re:Cognition Health operates an expanding network of leading specialised clinical trial centres collaborating with leading global pharmaceutical research companies with the commitment to being part of creating a world of healthy brains and minds through delivering successful trials of new disease-modifying molecules and treatments for all forms of cognitive impairment.
About Re:Cognition Health
Our Clinics
We have six clinics across the UK, including our head office in London’s Harley Street medical area. We also have four clinics throughout the USA.
Clinical Trials
Investing in research to change the future of brain and mind health
Our clinics in Birmingham, Bristol, Guildford, London, Plymouth and Winchester are leading centres for Alzheimer’s research. We provide access to new-generation drugs through a number of research studies.
Over 340 Patient Reviews
We can’t wait to meet you.
Reach out to our specialists today so that we can help you meet your cognitive healthcare needs.
Sign Up for Our Newsletter
Get our latest news, insights, and expert knowledge
"*" indicates required fields